Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
- 9 December 2011
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 71 (4) , 560-568
Abstract
Objective: Rapid eye movement sleep behavior disorder (RBD) is common in Parkinson disease (PD), but its relationship to the varied neurotransmitter deficits of PD and prognostic significance remain incompletely understood. RBD and cholinergic system degeneration are identified independently as risk factors for cognitive impairment in PD. We aimed to assess the association between cholinergic denervation and symptoms of RBD in PD patients without dementia.Methods: Eighty subjects with PD without dementia (age, 64.6 ± 7.0 years; range, 50–82 years; 60 males, 20 females; mean Montreal Cognitive Assessment Test [MoCA] score, 26.2 ± 2.1; range 21–30) underwent clinical assessment, neuropsychological testing, and [11C]methylpiperidyl propionate acetylcholinesterase and [11C]dihydrotetrabenazine (DTBZ) vesicular monoamine transporter type 2 positron emission tomography (PET) imaging. 11C3‐Amino‐4‐(2‐dimethylaminomethyl‐phenylsulfaryl)‐benzonitrile (DASB) serotonin transporter PET imaging was performed in a subset of 35 subjects. The presence of RBD symptoms was determined using the Mayo Sleep Questionnaire.Results: Twenty‐seven of 80 subjects (33.8%) indicated a history of RBD symptoms. Subjects with and without RBD symptoms showed no significant differences in age, motor disease duration, MoCA, Unified Parkinson Disease Rating Scale motor scores, or striatal DTBZ binding. Subjects with RBD symptoms, in comparison to those without, exhibited decreased neocortical, limbic cortical, and thalamic cholinergic innervation (0.0213 ± 0.0018 vs 0.0236 ± 0.0022, t = 4.55, p < 0.0001; 0.0388 ± 0.0029 vs 0.0423 ± 0.0058, t = 2.85, p = 0.0056; 0.0388 ± 0.0025 vs 0.0427 ± 0.0042, t = 4.49, p < 0.0001, respectively). Brainstem and striatal DASB binding showed no significant differences between groups.Interpretation: The presence of RBD symptoms in PD is associated with relative neocortical, limbic cortical, and thalamic cholinergic denervation although not with differential serotoninergic or nigrostriatal dopaminergic denervation. The presence of RBD symptoms may signal cholinergic system degeneration. ANN NEUROL 2012;Keywords
This publication has 60 references indexed in Scilit:
- The cholinergic system and Parkinson diseaseBehavioural Brain Research, 2011
- Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorderNeuropathology and Applied Neurobiology, 2011
- Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohortSleep Medicine, 2011
- Reassessment of the structural basis of the ascending arousal systemJournal of Comparative Neurology, 2010
- Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's diseaseBrain, 2010
- REM sleep behavior disorderAnnals of the New York Academy of Sciences, 2010
- Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorderNeurology, 2009
- A simple synthesis of [11C]Dihydrotetrabenazine (DTBZ)Nuclear Medicine and Biology, 1997
- Modification of the stroop color word test improves differentiation between patients with mild head injury and matched controlsThe Clinical Neuropsychologist, 1992
- ParkinsonismNeurology, 1967